UiPath's ARR Nears $2 Billion: Can It Sustain the Growth Momentum?Zacks Investment Research • Thursday
Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?The Motley Fool • Thursday
UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid ExpansionThe Motley Fool • Thursday
UiPath (PATH) Declines More Than Market: Some Information for InvestorsZacks Investment Research • Tuesday
Fastly vs. UiPath: Which Artificial Intelligence Stock Is a Better Buy Going into 2027?The Motley Fool • 11/13/26
UiPath (PATH) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 11/10/26
UiPath Accelerates Enterprise AI Transformation with Google Cloud's Gemini for HealthcareBusiness Wire • 11/10/26
UiPath Named a Leader in Everest Group's 2026 Agentic Process Automation Platform and Full Suite APAP PEAK Matrix® AssessmentsBusiness Wire • 11/05/26
UiPath (PATH) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 11/02/26
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 10/23/26
UiPath (PATH) Dips More Than Broader Market: What You Should KnowZacks Investment Research • 10/14/26
Figma vs. UiPath: What Revenue Growth Trends Tell Investors About These Tech CompaniesThe Motley Fool • 10/14/26